Coverage / PFE / Trade Card

PFE

Pfizer Inc

OPPORTUNISTIC BUY 2026-08-08 Data 35 days old USD 26.76 Healthcare - Drug Manufacturers - GeneralAWAIT ENTRY
ACTIONABLEMethodology gates passed
62

Position levels

Currenttoday
USD 26.76
Buy <=wait / entry
USD 24.00
Trim >=take some off
USD 28.00
Thesis breakA cut to Pfizer's FY2026 revenue or adjusted EPS guidance, a Phase III failure i...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case29%100 / 10029.0
Base case50%62 / 10031.0
Bear case21%10 / 1002.1
Weighted conviction62 / 100 - OPPORTUNISTIC BUY

Top risks

  • Q2 2026 earnings beat with actual EPS $0.77 vs est $0.68 (+13.24%)
  • Consensus Buy rating from 28 analysts with average price target $28.64
  • Operational revenue growth of 7% excluding COVID products driven by key brands
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.